Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **suppressor of cancer cell invasion protein (SCAI)** is a transcriptional corepressor known to regulate cell migration and invasion, primarily through inhibition of the RhoA (Ras homolog gene family, member A)-Dia1 (diaphanous homolog 1) signaling pathway[4][1]. SCAI functions as a tumor suppressor by repressing MRTFA-induced (myocardin-related transcription factor A) SRF (serum response factor) transcriptional activity, influencing genes related to cell movement such as integrin ITGB1[4]. It is implicated in cancer biology, as its loss or dysfunction can promote tumor cell invasion and metastasis. SCAI is encoded by the C9orf126 gene and has several alternative names reflecting its identification in various studies and databases[4][2][5][6]. There are no known drug interactions, clinical biomarkers, or direct therapeutic targeting strategies for SCAI as of now.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Suppressor of cancer cell invasion protein (SCAI).